Hangzhou Tigermed Consulting Co., Ltd (SZSE:300347) announces a share repurchase program. Under the program, the company will repurchase up to CNY 1,000 million worth of its shares. The company will repurchase its shares at CNY 60 per share. The program will be valid for a period of 12 months.

On April 13, 2024, the company announced that it has adjusted its share repurchase price from CNY 60 per share to CNY 72 per share.